3d
Medpage Today on MSNStudy Questions Need to Hold SGLT2 Inhibitors Before SurgeryPreoperative use of SGLT2 inhibitors among patients with type 2 diabetes undergoing emergency surgery was not associated with ...
3d
Medpage Today on MSNSGLT2 Inhibitors May Slow Nonsevere Aortic Stenosis ProgressionFor the first time, researchers said SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis ...
If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.
Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...
SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.
Researchers have found in a new study that SGLT2 inhibitors may have disease-modifying effects in nonsevere aortic stenosis ...
A new study, authored by KBH Professor Jan Inge Henter and published in the New England Journal of Medicine, has investigated ...
Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results